This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ROGER KURLAN, MD; THERESA DIMITSOPULOS, MD
Rochester, NY

Arch Neurol. 1992;49(12):1231.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Selegiline is known to produce a variety of behavioral side effects, including hallucinations, nightmares, and sleep disturbance. A sensation of increased energy may occur at doses greater than 10 mg/d.¹ Hypomania has been reported in a patient who received selegiline 5 mg twice daily immediately following adrenalstriatal transplantation, and it was attributed to the interaction between the two therapies.² We read with interest the letter by Boyson³ regarding psychiatric effects of selegiline, and we want to share our experience with two patients in support of the occurrence of manic episodes as an adverse response to selegiline treatment.

Report of Cases.

—CASE 1.

—A 62-year-old woman with Parkinson's disease of several years' duration was being treated with carbidopa/levodopa, bromocriptine, trihexyphenadyl, and nortriptyline. Selegiline was added to treat wearing-off phenomena, beginning with 5 mg daily and increasing to 5 mg twice daily. Within 7 . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?